Four Tree Island Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36M Hold
58,337
1.11% 12
2026
Q1
$3.54M Hold
58,337
1.79% 10
2025
Q4
$3.15M Sell
58,337
-793
-1% -$38.1K 1.74% 10
2025
Q3
$2.67M Hold
59,130
1.7% 10
2025
Q2
$2.74M Sell
59,130
-7,426
-11% -$365K 1.93% 10
2025
Q1
$4.06M Buy
66,556
+14,783
+29% +$862K 2.85% 10
2024
Q4
$2.93M Buy
+51,773
New +$2.89M 2.02% 13

Other funds holding BMY

Four Tree Island Advisory's BMY Position: Q2 2026 in Review

Four Tree Island Advisory held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 58,337 shares worth $3.36M. The position accounts for 1.11% of the portfolio, ranked #12.

Four Tree Island Advisory first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.06M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Four Tree Island Advisory held 58,337 shares of Bristol-Myers Squibb worth $3.36M as of Q2 2026.
  • Four Tree Island Advisory left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 1.11% of Four Tree Island Advisory's portfolio in Q2 2026, its #12 holding.
  • Four Tree Island Advisory first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Four Tree Island Advisory's Bristol-Myers Squibb position peaked at $4.06M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Four Tree Island Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.